asomani90 said...
I'm currently weighing my options between etrolizumab and vedolizumab...
Interesting choices. I hadn't heard of etrolizumab, it's still in stage iii trials. Vedolizumab (entvyio) some here use. Both are site-specific immunomodulators (ssi's) that involve madcam1, unlike other anti-tnf biologics which are systematic. Is your gastroenterologist involved in the trials?
www.etrostudiesresearch.com/